Directory of funded grants

Filter by

800 results found

Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Arthur J. Hudson Translational Team Grant

  • Province

    Ontario

  • Start Date

    2015

  • Total Grant Amount

    $1,382,685

  • Health Canada Contribution

    $691,342

Project Overview

The four most commonly studied ALS proteins are SOD1, TDP-43, FUS and C9ORF72. Of these, TDP-43 and FUS have the most in common. Not only do they share similar functions inside cells, but in motor neurons of people with ALS, they both accumulate in clumps outside of the area where…

Project Complete

See the project and researchers

Preclinical and clinical studies with withanolides: Therapeutic effects, molecular signatures and biomarkers

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Arthur J. Hudson Translational Team Grant

  • Province

    Québec

  • Start Date

    2015

  • Total Grant Amount

    $2,478,763

  • Health Canada Contribution

    $1,239,381

Project Overview

One of the hallmarks of ALS is the presence of abnormal clumps inside motor neurons that contain various substances which include, in the majority of cases, something called TAR DNA-binding protein 43 (TDP-43). As a result, understanding the mechanisms by which TDP-43 may influence the disease may have a tremendous impact…

Project Complete

See the project and researchers

Novel MRI biomarkers for monitoring disease progression in ALS

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Arthur J. Hudson Translational Team Grant

  • Province

    Alberta

  • Start Date

    2016

  • Total Grant Amount

    $2,946,303

  • Health Canada Contribution

    $1,473,151

Project Overview

For this project Dr. Sanjay Kalra and his team aims to improve on current techniques to use magnetic resonance imaging (MRI) as a readily available way to examine if a potential new treatment is working to slow down progression of ALS. Preliminary work by Dr. Kalra has revealed that using…

Project Ongoing

See the project and researchers

Selective knockdown of misfolded SOD1 as a therapy for amyotrophic lateral sclerosis

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Arthur J. Hudson Translational Team Grant

  • Province

    Manitoba

  • Start Date

    2015

  • Total Grant Amount

    $1,600,250

  • Health Canada Contribution

    $800,125

Project Overview

In some cases of ALS, it is clear that specific inherited genetic changes (called mutations) can not only cause the disease, but can do so by creating a protein (the end product of genes that actually does a function in our cells) that has an abnormal, toxic function resulting in…

Project Complete

See the project and researchers

The role of peripheral inflammation in ALS: an exploratory study

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    British Columbia

  • Start Date

    2015

  • Total Grant Amount

    $100,000

  • Health Canada Contribution

    $50,000

Project Overview

It has been more than a decade since scientists proved that ALS is not simply a disease of motor neurons, but that other cells in the neighbourhood around them could play an active role in the disease process. A series of intricate experiments demonstrated that genetically ‘turning off’ ALS in…

Project Complete

See the project and researchers